CHICAGO, June 24 (Reuters) - U.S. cancer diagnostic test maker Grail, which will list its shares on the Nasdaq on Tuesday after being spun out of Illumina (ILMN.O ...
June 25 (Reuters) - Shares of Grail (GRAL.O), opens new tab fell as much as 13.7% in their market debut on Tuesday after being spun out of gene-sequencing company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results